Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 69.24M P/E - EPS this Y 9.40% Ern Qtrly Grth -
Income -28.13M Forward P/E -3.57 EPS next Y -6.90% 50D Avg Chg 29.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 67.00%
Dividend N/A Price/Book 1.50 EPS next 5Y - 52W High Chg -24.00%
Recommedations 2.00 Quick Ratio 4.25 Shares Outstanding 68.27M 52W Low Chg 138.00%
Insider Own 4.42% ROA -37.71% Shares Float 65.19M Beta 0.71
Inst Own 13.47% ROE -69.93% Shares Shorted/Prior 275.24K/272.98K Price 1.07
Gross Margin - Profit Margin - Avg. Volume 153,230 Target Price 7.52
Oper. Margin - Earnings Date May 17 Volume 236,640 Change -0.93%
About Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

Cardiol Therapeutics Inc. News
05:00 AM Cardiol Therapeutics Announces Year-End 2023 Update on Operations
02/21/24 Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
02/15/24 Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis
01/24/24 Cardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital Market
01/09/24 Cardiol Therapeutics Announces it has Exceeded 50% Enrollment in its Phase II ARCHER Trial in Acute Myocarditis
12/05/23 Cardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-Pilot
11/16/23 Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
11/01/23 Cardiol Therapeutics Announces It Has Exceeded 50% Enrollment in Its Phase II MAvERIC-Pilot Study in Recurrent Pericarditis
10/20/23 Cardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
10/10/23 Cardiol Therapeutics Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in a Model of Heart Failure with Preserved Ejection Fraction
09/26/23 Cardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare Conference
09/19/23 Cardiol Therapeutics Announces All Collaborating Clinical Research Centers Now Initiated and Eligible to Enroll Patients in ARCHER, a Phase II Trial of CardiolRx(TM) for the Treatment of Acute Myocarditis
08/09/23 Cardiol Therapeutics to Present at Canaccord Genuity 43rd Annual Growth Conference
06/29/23 Cardiol Therapeutics Reports Results of 2023 Annual General Meeting
06/27/23 Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 p.m. EDT
05/09/23 Sidoti's Micro-Cap Virtual May Conference
CRDL Chatroom

User Image TheWinningStock Posted - 2 hours ago

$MRNA <<<--if you like Moderna, you will love $IBRX $CRDL, the last two are saving people not killing them..

User Image TheWinningStock Posted - 7 hours ago

$CRDL <<<--another highly possible winner $IFRX $IBRX ..

User Image TheWinningStock Posted - 7 hours ago

$CRDL <<<--trying to fix what $MRNA screwed in people...

User Image JOEtv Posted - 11 hours ago

$CRDL CardiolRx 100,000 Patients X $10,000 per year = $1,000,000,000 in Annual Sales

User Image letsgopeeps Posted - 1 day ago

$CRDL $2.10 by 12:30. Mark my word

User Image Doozio Posted - 04/30/24

$CRDL chop chop huckleberries πŸ§ β°β™ΎοΈ

User Image letsgopeeps Posted - 04/30/24

$CRDL Was this just the beginning? 🀭

User Image Iceberg99 Posted - 04/30/24

$CRDL πŸš€πŸš€

User Image letsgopeeps Posted - 04/30/24

$CRDL Are we keep going?

User Image letsgopeeps Posted - 04/30/24

$CRDL Now we really having fun. πŸ₯‚

User Image JaxJake Posted - 04/30/24

$CRDL 21k bid @ 2 trying to prop it up

User Image TheWinningStock Posted - 04/30/24

$CRDL <<---promising - Pipeline below

User Image TheWinningStock Posted - 04/30/24

$CRDL <<<---- winner here $IBRX

User Image Stocktud Posted - 04/30/24

$CRDL news is coming?

User Image RealAvidTrader Posted - 04/30/24

$CDTX $CRDL $VTGN Easy $$$$$

User Image letsgopeeps Posted - 04/30/24

$CRDL Now we talking 😜

User Image letsgopeeps Posted - 04/30/24

$CRDL No we talking! 😜

User Image Thomas_04 Posted - 04/30/24

$CRDL big volume today

User Image Doozio Posted - 04/29/24

$Crdl scrabble bag it in 🧠⏰

User Image Thomas_04 Posted - 04/29/24

$CRDL Price Predictions for Phase 2 results news?

User Image Pricer Posted - 04/29/24

$CRDL Best value pharma stock on the market in my opinion! Loading up on this one before its a $20 stock when they hit phase 3 trials.

User Image RealAvidTrader Posted - 04/28/24

$CDTX $VTGN $CRDL πŸ’₯ 6 Stocks I'm Watching For This Week! πŸ’₯ https://youtu.be/-1KVmgQY0yk

User Image Iceberg99 Posted - 04/28/24

$CRDL I think this is going to take off again soon. Too many incredibly positive things to come, then it will rip like crazy!! πŸš€

User Image Isellputstoyou Posted - 04/26/24

$CRDL symmetrical triangle.

User Image RealAvidTrader Posted - 04/25/24

$CRDL $NRSN Analysts Gave This $1 Stock a $9 Price Target! https://youtu.be/E5_o8ZNIpgw

User Image Thomas_04 Posted - 04/25/24

$CRDL Phase 2, Pericarditis results will be huge for this stock. Right around 1 month away, this will be great.

User Image LilloG Posted - 04/25/24

$CRDL So little volume the stock price is updating every hour almost... Bring on some good news. Graphic is cleary showing its gonna go very high shortly..

User Image Iceberg99 Posted - 04/24/24

$KNSA $CRDL News Breaks April 24, 2024 KNSA Kiniksa price target raised to $30 from $25 at Evercore ISIEvercore ISI analyst Liisa Bayko raised the firm's price target on Kiniksa to $30 from $25 and keeps an Outperform rating on the shares. The firm cites two reasons it is "lovin' KNSA," namely that lead asset Arcalyst accelerating in recurrent pericarditis and that the company will be cash flow positive this year and beyond. The firm, which notes that it got some additional color on abiprubart on the earnings call, adds that it will "remain in wait and see mode before assigning more value," noting that value for the asset currently represents $5 of its $30 price target on Kiniksa shares.

User Image Iceberg99 Posted - 04/24/24

$CRDL I'm thinking news must be getting close. πŸ€”

User Image TickerDD_com Posted - 04/23/24

From 4/11/2024, looking back across 22 Month-Ends for CRDL, Percentage Change of Average Monthly Price had More Positives (55%) while Percentage Change of Average Monthly Volume had All Positives (100%) $CRDL #CRDL #CRDLStock #TickerDD https://www.youtube.com/watch?v=wtXJ7CeKDL0